Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.345 USD | -1.82% | -1.48% | -27.72% |
May. 21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Transcripts